Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-301814
Filing Date
2023-12-22
Accepted
2023-12-22 08:31:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d670920ddefa14a.htm DEFA14A 57945
  Complete submission text file 0001193125-23-301814.txt   58941
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

EIN.: 270605902 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38958 | Film No.: 231507226
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)